BIM
ANIK icon

Bridges Investment Management’s Anika Therapeutics ANIK Stock Holding History

Bridges Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,960
Closed -$1.15M – 272
2019
Q3 		$1.15M Sell
20,960
-3,690
-15% -$189K 0.04% 188
2019
Q2 		$1M Hold
24,650
– – 0.04% 194
2019
Q1 		$745K Buy
24,650
+4,830
+24% +$165K 0.03% 220
2018
Q4 		$666K Buy
+19,820
New +$715K 0.03% 226

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bridges Investment Management's ANIK Position: Q4 2019 in Review

Bridges Investment Management sold out of Anika Therapeutics (ANIK) in Q4 2019, closing a stake of 20,960 shares — an estimated $1.15M sold.

Bridges Investment Management first reported a position in ANIK in Q4 2018 and held it in 4 quarters. The position peaked at $1.15M in Q3 2019. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • Bridges Investment Management reported no remaining Anika Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Bridges Investment Management sold 20,960 Anika Therapeutics shares in Q4 2019, an estimated $1.15M.
  • Bridges Investment Management first reported a position in Anika Therapeutics in Q4 2018 and held it in 4 quarters.
  • Bridges Investment Management's Anika Therapeutics position peaked at $1.15M in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on Bridges Investment Management's 13F filing for Q4 2019, filed 18 Feb 2020.